News
We came across a bullish thesis on Verona Pharma plc (VRNA) on Capital Employed’s Substack by Patients Capital Management. In ...
Fintel reports that on July 14, 2025, HC Wainwright & Co. downgraded their outlook for Verona Pharma plc - Depositary Receipt ...
7h
TipRanks on MSNMerck Stock (MRK) Bulls Cheer $10Bn Verona Pharma GambleMerck & Co. ($MRK) is betting on acquisitions to offset the looming revenue loss from the upcoming patent expiration of ...
15h
Zacks.com on MSNMRK's Buyout Spree to Broaden Product Portfolio: Can it Aid Growth?Merck MRK recently intensified its acquisition strategy, actively pursuing deals to enhance its development pipeline and ...
Biotech stumbled in FY25, but we didn’t. HB Biotechnology kept its footing and delivered 23% outperformance in a tough market ...
23h
GlobalData on MSNFDA to review MSD’s doravirine/islatravir NDA for HIV-1The US Food and Drug Administration (FDA) has accepted MSD’s doravirine/islatravir (DOR/ISL) new drug application (NDA) for ...
Verona brings with it Ohtuvayre, an inhaled treatment for chronic obstructive pulmonary disease, often known as smoker's lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results